An Isothermal Calorimetry Assay for Determining Steady State Kinetic and Ensitrelvir Inhibition Parameters for SARS-CoV-2 3CL-protease

Overview

Journal Sci Rep

Specialty Science

Date 2024 Dec 31

PMID 39741150

Authors

Luca Mazzei

Sofia Ranieri

Davide Silvestri

Rebecca Greene-Cramer

Christopher Cioffi

Gaetano T Montelione

Stefano Ciurli

Affiliations

Soon will be listed here.

Abstract

This manuscript details the application of Isothermal Titration Calorimetry (ITC) to characterize the kinetics of 3CL, the main protease from the Severe Acute Respiratory Syndrome CoronaVirus-2 (SARS-CoV-2), and its inhibition by Ensitrelvir, a known non-covalent inhibitor. 3CL is essential for producing the proteins necessary for viral infection, which led to the COVID-19 pandemic. The ITC-based assay provided rapid and reliable measurements of 3CL activity, allowing for the direct derivation of the kinetic enzymatic constants K and k by monitoring the thermal power required to maintain a constant temperature as the substrate is consumed. The manuscript highlights several advantages of the proposed ITC-based assay over traditional methods used to study 3CL, such as Förster Resonance Energy Transfer (FRET) and Liquid Chromatography-Mass Spectrometry (LC-MS) and overcomes the need for non-biological substrates or discontinuous post-reaction steps. The ease of application of the ITC method allowed for the determination of the temperature dependence of the catalytic constants, enabling the estimation of the reaction activation energy. Additionally, the assay was used to determine the inhibition mode and kinetic parameters for 3CL inhibition by Ensitrelvir. This molecule was revealed to act as a slow- and tight-binding inhibitor that forms an initial E•I complex (K = 9.9 ± 0.7 nM) quickly transitioning to a tighter E•I* assembly (K* = 1.1 ± 0.2 nM). This versatile calorimetric method is proposed for general use in the discovery and development of drugs targeting 3CL.

References

Lin M, Zeng X, Duan Y, Yang Z, Ma Y, Yang H . Molecular mechanism of ensitrelvir inhibiting SARS-CoV-2 main protease and its variants. Commun Biol. 2023; 6(1):694. PMC: 10322880. DOI: 10.1038/s42003-023-05071-y. View

Stille J, Tjutrins J, Wang G, Venegas F, Hennecker C, Rueda A . Design, synthesis and in vitro evaluation of novel SARS-CoV-2 3CL covalent inhibitors. Eur J Med Chem. 2022; 229:114046. PMC: 8665847. DOI: 10.1016/j.ejmech.2021.114046. View

Pettersen E, Goddard T, Huang C, Couch G, Greenblatt D, Meng E . UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem. 2004; 25(13):1605-12. DOI: 10.1002/jcc.20084. View

Kuzikov M, Costanzi E, Reinshagen J, Esposito F, Vangeel L, Wolf M . Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing Screen. ACS Pharmacol Transl Sci. 2022; 4(3):1096-1110. PMC: 7986981. DOI: 10.1021/acsptsci.0c00216. View

Noske G, Song Y, Fernandes R, Chalk R, Elmassoudi H, Koekemoer L . An in-solution snapshot of SARS-COV-2 main protease maturation process and inhibition. Nat Commun. 2023; 14(1):1545. PMC: 10027274. DOI: 10.1038/s41467-023-37035-5. View

Elsasser B, Goettig P . Mechanisms of Proteolytic Enzymes and Their Inhibition in QM/MM Studies. Int J Mol Sci. 2021; 22(6). PMC: 8004986. DOI: 10.3390/ijms22063232. View

El-Baba T, Lutomski C, Kantsadi A, Malla T, John T, Mikhailov V . Allosteric Inhibition of the SARS-CoV-2 Main Protease: Insights from Mass Spectrometry Based Assays*. Angew Chem Int Ed Engl. 2020; 59(52):23544-23548. PMC: 7461284. DOI: 10.1002/anie.202010316. View

Suryawanshi R, Koganti R, Agelidis A, Patil C, Shukla D . Dysregulation of Cell Signaling by SARS-CoV-2. Trends Microbiol. 2021; 29(3):224-237. PMC: 7836829. DOI: 10.1016/j.tim.2020.12.007. View

Gao K, Wang R, Chen J, Tepe J, Huang F, Wei G . Perspectives on SARS-CoV-2 Main Protease Inhibitors. J Med Chem. 2021; 64(23):16922-16955. PMC: 9357291. DOI: 10.1021/acs.jmedchem.1c00409. View

10.

Kasparek A, Smyk B . A new approach to the old problem: Inner filter effect type I and II in fluorescence. Spectrochim Acta A Mol Biomol Spectrosc. 2018; 198:297-303. DOI: 10.1016/j.saa.2018.03.027. View

11.

Forman R, Azzopardi-Muscat N, Kirkby V, Lessof S, Nathan N, Pastorino G . Drawing light from the pandemic: Rethinking strategies for health policy and beyond. Health Policy. 2021; 126(1):1-6. PMC: 8645287. DOI: 10.1016/j.healthpol.2021.12.001. View

12.

Wang Y, Wang G, Moitessier N, Mittermaier A . Enzyme Kinetics by Isothermal Titration Calorimetry: Allostery, Inhibition, and Dynamics. Front Mol Biosci. 2020; 7:583826. PMC: 7604385. DOI: 10.3389/fmolb.2020.583826. View

13.

Liu Y, Kati W, Chen C, Tripathi R, Molla A, Kohlbrenner W . Use of a fluorescence plate reader for measuring kinetic parameters with inner filter effect correction. Anal Biochem. 1999; 267(2):331-5. DOI: 10.1006/abio.1998.3014. View

14.

Transtrum M, Hansen L, Quinn C . Enzyme kinetics determined by single-injection isothermal titration calorimetry. Methods. 2014; 76:194-200. DOI: 10.1016/j.ymeth.2014.12.003. View

15.

Copeland R . Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists. Methods Biochem Anal. 2005; 46:1-265. View

16.

Noske G, Nakamura A, Gawriljuk V, Fernandes R, Lima G, Rosa H . A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process. J Mol Biol. 2021; 433(18):167118. PMC: 8223035. DOI: 10.1016/j.jmb.2021.167118. View

17.

Duan Y, Zhou H, Liu X, Iketani S, Lin M, Zhang X . Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir. Nature. 2023; 622(7982):376-382. DOI: 10.1038/s41586-023-06609-0. View

18.

Li F, Fang T, Guo F, Zhao Z, Zhang J . Comprehensive Understanding of the Kinetic Behaviors of Main Protease from SARS-CoV-2 and SARS-CoV: New Data and Comparison to Published Parameters. Molecules. 2023; 28(12). PMC: 10304930. DOI: 10.3390/molecules28124605. View

19.

Rawlings N, Barrett A, Bateman A . MEROPS: the database of proteolytic enzymes, their substrates and inhibitors. Nucleic Acids Res. 2011; 40(Database issue):D343-50. PMC: 3245014. DOI: 10.1093/nar/gkr987. View

20.

Xue X, Yang H, Shen W, Zhao Q, Li J, Yang K . Production of authentic SARS-CoV M(pro) with enhanced activity: application as a novel tag-cleavage endopeptidase for protein overproduction. J Mol Biol. 2006; 366(3):965-75. PMC: 7094453. DOI: 10.1016/j.jmb.2006.11.073. View